comparemela.com

Latest Breaking News On - Otcmkts enzn - Page 1 : comparemela.com

Reviewing Gilead Sciences (NASDAQ:GILD) & Enzon Pharmaceuticals (OTCMKTS:ENZN)

Enzon Pharmaceuticals (OTCMKTS:ENZN – Get Free Report) and Gilead Sciences (NASDAQ:GILD – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Enzon Pharmaceuticals […]

Enzon Pharmaceuticals, Inc (OTCMKTS:ENZN) Short Interest Update

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) saw a large decline in short interest in December. As of December 31st, there was short interest totalling 1,600 shares, a decline of 42.9% from the December 15th total of 2,800 shares. Based on an average daily trading volume, of 83,600 shares, the days-to-cover ratio is currently […]

Enzon Pharmaceuticals, Inc (OTCMKTS:ENZN) Short Interest Down 58 2% in December

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) saw a large drop in short interest in December. As of December 15th, there was short interest totalling 2,800 shares, a drop of 58.2% from the November 30th total of 6,700 shares. Based on an average trading volume of 43,500 shares, the days-to-cover ratio is currently 0.1 […]

Enzon Pharmaceuticals, Inc (OTCMKTS:ENZN) Short Interest Up 318 8% in November

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 6,700 shares, a growth of 318.8% from the November 15th total of 1,600 shares. Based on an average trading volume of 116,900 shares, […]

Novavax (NASDAQ:NVAX) vs Enzon Pharmaceuticals (OTCMKTS:ENZN) Critical Analysis

Enzon Pharmaceuticals (OTCMKTS:ENZN – Get Free Report) and Novavax (NASDAQ:NVAX – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk. Analyst Recommendations This is a breakdown of current ratings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.